Is Regeneron (NASDAQ: REGN) making money?

The antibodies in the cocktail resemble the antibodies found in coronavirus survivors’ blood, the MIT Technology Review claims. Trump’s physicians hope Regeneron’s cocktail could reprogram the president’s immune system to destroy coronavirus.

Continue Reading Is Regeneron (NASDAQ: REGN) making money?

End of content

No more pages to load